XOMA Provides Update on Gevokizumab Proof-of-Concept Program
Go back to XOMA Provides Update on Gevokizumab Proof-of-Concept Program| XOMA (NASDAQ: XOMA) | Delayed: 42.00 +0.11 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.89 | 52 Week High | $7.33 | |||
| Open | $42.05 | 52 Week Low | $0.34 | |||
| Day High | $42.16 | P/E | N/A | |||
| Day Low | $41.85 | EPS | $-0.73 | |||
| Volume | 105,497 | |||||
